Paact.help – Prostate Advocates Aiding Choices in Treatments

In the U.S., over 73,000 men are estimated to be diagnosed with castration-resistant prostate cancer (CRPC) in 2019.2 About 40 percent of these patients have prostate cancer that has not spread to other parts of the body and is also associated with a rising prostate-specific antigen (PSA) level, despite a castrate testosterone level, which is known as nmCRPC.2,3 This is important because about ... ................
................

In order to avoid copyright disputes, this page is only a partial summary.

Google Online Preview   Download